A phase II study of the efficacy of the combination of ofatumumab with fludarabine and cyclophosphamide in patients with relapsed or refractory Waldenstrom's Macroglobulinemia.
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2016
At a glance
- Drugs Ofatumumab (Primary) ; Cyclophosphamide; Fludarabine
- Indications Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 06 Mar 2013 New trial record